Cardiology Perspective

 
 
  • The Latest Attack on Low-Carb Diets: Science or Politics? A recent paper in Lancet Public Health announced that low-carb diets are associated with increased mortality. But are the study's conclusions based on sound scientific evidence?
  • A 52-Year-Old Man With Dyspnea: USMLE Question A 52-year-old man presents with progressive dyspnea and purulent sputum production. What's the most likely diagnosis?
  • Beta-Blockade After MI: No Practice Should Be Set in Stone Meta-analyses suggest little benefit for beta-blockers in contemporary patients with normal ejection fraction after MI. What other dogma should be revisited in light of an evolving evidence base?
  • Cardio Twitter Brings ESC Congress to the Masses #CardioTwitter had a strong pulse at the European Society of Cardiology meeting.
  • PURE and Simple Diet Lowers Mortality, CVD Events   The global PURE study identified seven dietary components which, in moderation, may be associated with a reduced risk for premature mortality. Dr Mandrola learns more from investigator Dr Andrew Mente.
  • Who Is the 'Cardiometabolic Specialist'?   With new diabetes drugs available that lower cardiovascular risk, the question arises over which specialty will manage this area of medicine. Or will a new specialty emerge?
  • Sep 7, 2018 This Week in Cardiology   High sensitivity troponin, radial access (a good news story!), stroke care, rivaroxaban in CAD and PAD, and the components of a healthy diet are discussed in this week’s podcast.
  • Renal Denervation: Is It Ready for Prime Time?   Dr Lynda Szczech discusses recent trial results demonstrating the safety and efficacy of this procedure.
  • ESC 2018Will GLOBAL LEADERS Change Dual Antiplatelet Therapy Regimens?   Drs Christopher Granger and Adnan Kastrati discuss the implications of the GLOBAL LEADERS trial comparing ticagrelor monotherapy with DAPT 1 year after stenting for acute or stable coronary disease.
  • The Problem With Diet Studies: We Don't Eat Macronutrients The Lancet Public Health recently published a study suggesting that both low- and high-carbohydrate diets are associated with increased mortality. The problem? People eat food, not macronutrients.
  • ESC 2018Aspirin in Primary Prevention: Lessons From ASCEND   The ESC hotline ASCEND trial on low-dose aspirin for primary CV prevention in people with diabetes is reviewed with presenter Prof Armitage.
  • Aug 31, 2018 This Week in Cardiology   Dr John Mandrola offers a wrap-up of the ESC meeting in this week's podcast
  • The Disappearing Palpitations By the time this young man gets to the ED, his palpitations are gone. What does his ECG show?
  • ESC 2018Don't Ignore the Many Lessons of the MitraClip Failure Reflecting on the MITRA-FR trial, Dr John Mandrola says it can help us learn both specific lessons about the treatment of people with heart failure and more general lessons on the acceptance of untested therapeutics.
  • Is IO Inferior to IV Access in Out-of-Hospital Cardiac Arrest? Dr Patel reviews a study that examines the effect of intraosseous vs intravenous vascular access on patient outcomes after out-of-hospital cardiac arrest.
  • ESC 2018Do Cardiologists Care About CV Prevention? Everyone agrees that prevention is better than cure. However, few ESC attendees joined Melissa Walton-Shirley for the session on CVD prevention, preferring to stand in line to hear the latest hotlines.
  • ESC 2018Fish Oils Off the Menu for People With Diabetes   Prof Bowman discusses the ASCEND findings on omega-3 fatty acids for cardiovascular prevention in people with type 2 diabetes, presented at the European Society of Cardiology congress.
  • ESC 2018Aspirin in Primary Prevention: Lessons From ARRIVE   The ARRIVE trial compared low-dose aspirin with placebo in middle-aged men and women at moderate CV risk. Investigator J. Michael Gaziano gives John Mandrola the details.
  • ESC 2018Ten Things I Learned About Aspirin at ESC Two neutral trials inform an everyday clinical question: who should take aspirin for primary prevention of cardiovascular disease. John Mandrola spoke with both investigators; these are his takeaways.
  • ESC 2018Cardiology 2028: Predicting the Future Melissa Walton-Shirley attended a session at the European Society of Cardiology Congress titled "Cardiology 10 Years From Now" and heard some realistic predictions.